The YLL006W-A antibody targets the protein encoded by the YLL006W-A gene in Saccharomyces cerevisiae. This gene is annotated as a hypothetical open reading frame (ORF) with limited functional characterization. The antibody is produced by immunizing rabbits with recombinant YLL006W-A protein, enabling specific recognition of this antigen in immunoassays .
While the YLL006W-A protein’s function remains uncharacterized, genomic studies associate it with mitochondrial processes. Large-scale mitochondrial proteome profiling efforts, such as the "Y3K" project, have identified YLL006W as a target strain for systematic functional annotation, suggesting potential roles in oxidative phosphorylation or metabolite biosynthesis .
The YLL006W-A antibody enables:
Localization studies: Tracking YLL006W-A expression under varying metabolic conditions.
Protein interaction assays: Identifying binding partners in yeast proteomic screens.
Validation of gene deletion strains: Confirming the absence of YLL006W-A in mutant yeast lines .
Specificity constraints: Cross-reactivity with homologous yeast proteins cannot be ruled out without further validation.
Functional insights: The antibody’s utility depends on advancing research into YLL006W-A’s biological role, which remains a gap in mitochondrial biochemistry .
- Hoelzel Biotech. (2025). YLL006W-A Antibody Product Specifications.
- Stefely, J. A., & Pagliarini, D. J. (2025). Biochemical Functions of Mitochondrial ADCK3 and Other Uncharacterized Proteins. University of Wisconsin-Madison.
KEGG: sce:YLL006W-A
YLL006W-A is a yeast gene identified in Saccharomyces cerevisiae. While the search results do not specifically detail the function of YLL006W-A, they demonstrate the convention for yeast gene nomenclature, where genes are typically denoted with italicized capital letters (e.g., CKA1) . YLL006W-A would follow this convention, representing a specific open reading frame (ORF) in the yeast genome. When studying this gene's function, researchers typically employ deletion mutants (denoted with the delta symbol, e.g., cka2Δ) to understand how loss of the gene affects cellular processes . Analysis of phenotypic changes in such deletion mutants can reveal involvement in specific cellular pathways, similar to how researchers have identified roles for genes like CKA2 in metal ion toxicity mechanisms.
Validation of antibody specificity for yeast proteins requires multiple methodological approaches:
Genetic controls: Test antibody reactivity against wild-type and YLL006W-A deletion mutants to confirm specificity
Cross-reactivity assessment: Evaluate binding to related yeast proteins to ensure target specificity
Western blot analysis: Perform immunoblotting with appropriate positive and negative controls
Immunoprecipitation verification: Confirm that the antibody can specifically capture the YLL006W-A protein product
The scientific rigor demonstrated in metal ion toxicity studies, where researchers verified CK2 involvement through both genetic and pharmacological approaches (e.g., TBB inhibitor studies), exemplifies how validation should be conducted .
For monitoring YLL006W-A expression across different growth phases, researchers should consider:
Quantitative PCR (qPCR): For measuring transcript levels, similar to techniques used in metal toxicity studies
Western blotting: For protein level quantification with appropriate normalization to housekeeping proteins
Fluorescent protein tagging: Creating fusion proteins for live-cell imaging of expression dynamics
Flow cytometry: For population-level analysis of protein expression in yeast cultures
The selection of technique should be guided by experimental questions. For instance, if investigating YLL006W-A's response to environmental stressors (like metal ions), time-course analyses similar to those conducted at various time points (T0, T16, T20, T24) in metal toxicity studies would be appropriate .
While specific information about YLL006W-A's role in metal ion homeostasis is not directly provided in the search results, we can infer potential methodologies based on similar studies:
Research into protein kinase CK2 subunits demonstrated distinct roles in metal ion toxicity. For example, CKA2 deletion conferred resistance to Al³⁺ and Zn²⁺, with ICP-MS analysis showing that cka2Δ exhibited 52-85% reduction in Al³⁺ content compared to wildtype . To investigate YLL006W-A's potential involvement in metal homeostasis, researchers should:
Generate YLL006W-A deletion mutants and assess growth under various metal stress conditions
Perform ICP-MS quantification of intracellular metal content in wildtype versus deletion strains
Create double deletion mutants with known metal homeostasis genes to identify genetic interactions
Employ transcriptomics to determine if YLL006W-A expression changes in response to metal exposure
This methodological approach parallels how researchers uncovered CKA2's role in Al³⁺ uptake independent of other CK2 subunits .
Addressing functional redundancy requires systematic approaches:
Generation of multiple deletion mutants: Create single, double, and triple mutants with genes suspected of redundancy
Phenotypic profiling: Assess growth characteristics under various stress conditions (e.g., metal ions, oxidative stress)
Pharmacological inhibition: Combine genetic deletion with chemical inhibitors to block potentially compensating pathways
Rescue experiments: Test if overexpression of related genes can complement YLL006W-A deletion phenotypes
The approach used to investigate CK2 function provides a methodological template: researchers created double deletion mutants (CKA2 with either CKB1 or CKB2) and combined this with CK2 inhibition using TBB to reveal that CKA2's role in Al³⁺ toxicity was independent of other CK2 subunits, while its role in Zn²⁺ response involved the remaining CK2 complex .
Optimizing antibody-based approaches for studying protein-metal transporter interactions requires:
Co-immunoprecipitation optimization: Adjust buffer conditions to preserve weak or transient interactions
Proximity labeling techniques: Employ BioID or APEX2 fusion proteins to identify proximal interacting partners
In situ crosslinking: Use membrane-permeable crosslinkers to capture transient interactions before cell lysis
Fluorescence resonance energy transfer (FRET): Develop fluorescently tagged proteins to visualize interactions in live cells
These methodologies would be particularly relevant when investigating potential interactions between YLL006W-A and zinc transporters like ZNT or ZRT mentioned in the search results , which could reveal mechanistic insights into metal homeostasis pathways.
Critical controls for ChIP experiments with YLL006W-A antibodies include:
Input control: Unprocessed chromatin to normalize for DNA abundance
No-antibody control: Procedure without antibody to identify non-specific binding
Isotype control: Irrelevant antibody of same isotype to detect background binding
Gene deletion control: ChIP in YLL006W-A deletion strain to confirm specificity
Positive control regions: Known binding sites of similar transcription factors
Negative control regions: Genomic regions not expected to bind the protein
When designing experiments similar to those investigating metal-responsive elements (MREs) in metal toxicity studies , ensure appropriate positive controls for technical validation and biological interpretation.
A comprehensive experimental design should include:
This approach parallels the time-course analyses and metal exposure methodologies used to characterize the role of CK2 subunits in metal toxicity .
To minimize cross-reactivity concerns:
Pre-absorption: Incubate antibody with lysates from YLL006W-A deletion strains to remove cross-reactive antibodies
Epitope mapping: Identify unique epitopes in YLL006W-A for improved antibody design
Competition assays: Perform binding in presence of purified YLL006W-A protein to demonstrate specificity
Western blot optimization: Adjust blocking conditions and antibody concentrations to reduce background
Mass spectrometry validation: Confirm identity of immunoprecipitated proteins via MS analysis
These approaches ensure antibody specificity similar to how researchers validated CK2 subunit functions through complementary genetic and biochemical techniques .
To enhance detection of low-abundance proteins:
Signal amplification: Implement tyramide signal amplification for immunofluorescence
Subcellular fractionation: Enrich for specific cellular compartments before analysis
Protein concentration: Use techniques like TCA precipitation to concentrate proteins
Advanced microscopy: Employ super-resolution techniques for better visualization
Targeted proteomics: Develop selected reaction monitoring (SRM) mass spectrometry assays
These approaches would be particularly valuable when studying proteins involved in metal homeostasis, which may exhibit compartment-specific functions as suggested by research on zinc transporters (ZNT, ZRT) and vacuolar membrane zinc transporters (ZRC1) .
When facing contradictory results:
Technical validation: Verify both antibody specificity and reporter construct functionality
Temporal considerations: Assess whether protein and transcript levels might be temporally uncoupled
Post-translational modifications: Determine if antibodies detect specific protein states that reporters cannot capture
Subcellular localization: Examine if differences reflect compartment-specific detection limitations
Systematic troubleshooting: Create a decision tree to methodically test each variable
The approach used to resolve apparently contradictory findings regarding CKA2's role in Al³⁺ versus Zn²⁺ resistance provides a template: researchers systematically employed double deletions, inhibitors, and direct metal measurements to reveal distinct mechanisms .
Appropriate statistical analyses include:
For growth assays: Repeated measures ANOVA with post-hoc tests to assess significance across time points
For protein quantification: Non-parametric tests when assumptions of normality cannot be met
For microscopy data: Mixed-effects models to account for cell-to-cell variability
For metal content analyses: Similar to the ICP-MS approaches used in CK2 studies , paired t-tests or ANOVA with appropriate corrections for multiple comparisons
For time-course experiments: Time-series analysis methods accounting for temporal autocorrelation
Importantly, researchers should report standard error of the mean (SEM) as done in metal toxicity studies and implement appropriate statistical power calculations during experimental design.
YLL006W-A research could provide insights into neurodegenerative disease mechanisms through:
Pathway conservation analysis: Identify human orthologs of YLL006W-A and associated proteins
Metal homeostasis mechanisms: Investigate shared pathways between yeast and neuronal cells
Disease model development: Use yeast as a simplified model for studying toxic metal accumulation
The search results highlight connections between metal dysregulation and neurodegenerative diseases: zinc affects Aβ precipitation in Alzheimer's disease, altered zinc binding in SOD1 is linked to ALS, and elevated zinc levels are observed in the substantia nigra in Parkinson's disease . YLL006W-A studies could potentially reveal novel mechanisms relevant to these conditions if it participates in conserved metal homeostasis pathways.
Active learning methodologies can enhance experimental efficiency:
Iterative experimental design: Begin with small-scale experiments and use results to guide subsequent larger studies
Machine learning prediction: Apply algorithms to predict potential interaction partners based on limited initial data
Library-on-library screening optimization: Implement approaches similar to those described for antibody-antigen binding prediction
As demonstrated in recent antibody research, active learning strategies reduced the number of required antigen mutant variants by up to 35% and accelerated the learning process by 28 steps compared to random approaches . Similar efficiency gains could be achieved in YLL006W-A interaction studies by strategically selecting experimental conditions based on preliminary results.
Effective interdisciplinary strategies include:
Computational structural biology: Predict protein-metal binding sites and interaction interfaces
Systems biology: Integrate transcriptomic, proteomic, and metabolomic data to place YLL006W-A in broader networks
Chemical biology: Develop small molecule probes to perturb YLL006W-A function
Evolutionary biology: Compare YLL006W-A across fungal species to identify conserved functional domains
These approaches mirror the integrative strategies used to study protein kinase CK2 in metal ion toxicity, where genetic, biochemical, and analytical methods were combined to elucidate specific mechanisms .
Integrative analytical approaches should:
Combine immunological and spectroscopic methods: Couple immunoprecipitation with ICP-MS to determine metal binding similar to approaches used in CK2 studies
Integrate genetic and proteomic analyses: Correlate phenotypes of deletion mutants with changes in protein abundance and modification
Merge structural and functional studies: Connect antibody epitope mapping with functional domains of the protein
Link temporal dynamics across methods: Align time-course data from different analytical platforms